Thanks for following along. For more information or to access a replay of today’s call, visit: $CURA $CURLF.

“We expect a meaningful improvement in operating cash flow in the second half of the year, in line with our historical pattern of stronger cash generation in the back half.” $CURA $CURLF.

“In the second quarter, we generated operating cash flow from continuing operations of $9 million dollars driven by changes in working capital as we saw an increase in wholesale sales in the last month of the quarter.” $CURA $CURLF.

“Second quarter adjusted EBITDA was $66 million dollars, a decrease of 10% compared to last year, while adjusted EBITDA margin was 21%.” $CURA $CURLF.

Curaleaf CFO, Ed Kremer: “Our second quarter adjusted gross profit was $154 million dollars, resulting in a 49% adjusted gross margin, an increase of 120 basis points compared to the prior year period.” $CURA $CURLF.

@Boris_Jordan “To our entire team: thank you. With your continued focus and execution, I believe Curaleaf is exceptionally well positioned to lead the next era of cannabis.” $CURA $CURLF.

@Boris_Jordan “We’ve laid critical groundwork to strengthen the business—resetting garden yields, elevating flower quality across our network, expanding gross margins, reducing costs, and fueling growth. " $CURA $CURLF.

@Boris_Jordan “Our international strategy continues to deliver results, driven by disciplined execution and a focus on scalable, high-growth markets.” $CURA $CURLF.

@Boris_Jordan “We are pleased to announce we have received a license to enter Turkey, providing us a first mover advantage in the country’s nascent medical market.” $CURA $CURLF.

@Boris_Jordan "Over the past 15 months, we have overhauled our genetics library to deliver high-quality, consistent flower across our state footprint.” $CURA $CURLF.

@Boris_Jordan “Select remained the #1 vape brand in the U.S. during Q2, while Grassroots—our premium flower offering—was a top 3 flower brand, according to BDSA.” $CURA $CURLF.

@Boris_Jordan “Anthem is already outperforming expectations, and we are accelerating production to meet surging demand while scaling to add additional states.” $CURA $CURLF.

@Boris_Jordan “Our international segment continued to impress with another solid quarter of 17% sequential growth.” $CURA $CURLF.

@Boris_Jordan “We generated $66 million dollars in adjusted EBITDA resulting in a 21% AEBITDA margin, with international and hemp accounting for 260 basis points of margin drag.” $CURA $CURLF.

@Boris_Jordan “In the second quarter, we generated revenue of $315 million dollars, up 1.5% compared to the first quarter, consistent with our guidance for low single digit growth.” $CURA $CURLF.

Curaleaf Chairman and CEO @Boris_Jordan: “From the outset, rapidly growing the business has been central to my vision, recognizing that scale would be essential to navigating the inevitable volatility of the cannabis industry.” $CURA $CURLF.

As our Q2 2025 earnings conference call begins, follow along here for highlights and key commentary from the call. Details: $CURA $CURLF.

RT @Curaleaf_Inc: Here's a look at our Q2 2025 financial and operational results: Join us at 5PM ET tonight for ou….

RT @Curaleaf_Inc: Join us tonight at 5pm ET for our Q2 2025 earnings call. Details: $CURA $CURLF.

Thank you for following along – for more information or a replay of this call, head to $CURA $CURLF.